2 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 2 | Unknown 2 |
Follow CLL: new trials by email Literature Review of CLL trials Research Report on CLL
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL. GB261 - B Cell NHL, CLL | Phase 1 / Phase 2 | Unknown | Genor Biopharma Co., Ltd. | 460 | 2021-08-31 | 2023-05-22 |
| A Study of Obinutuzumab(GA101) in Combination With High-Dose Methylprednisolone(HDMP) in Chronic Lymphocytic Leukemia(CLL) Patients (GA101 & HDMP) GA101/HDMP - CLL | Phase 1 / Phase 2 | Unknown | University of California, San Diego | 40 | 2014-09-01 | 2023-08-30 |
Genor Biopharma Co., Ltd. (1) · University of California, San Diego (1)
Australia (1) · United States (1)
Kipps Thomas, MD (1)